September 16, 2010 — Treating β-thalassemia with gene therapy has enabled a young adult patient who received his first transfusion at age 3 years to live without transfusions for more than 2 years.
India's diverse demography poses significant health challenges, including susceptibility to genetic disorders such as thalassemia. India has the most important number of children with Thalassemia ...
Imagine going about your daily routine when suddenly you feel overwhelming fatigue, weakness, and pale skin. These everyday incidents may indicate a condition called thalassemia. Proper nutrition ...
A 10-year-old thalassemia patient in Koderma tested positive for HIV following blood transfusions at a government hospital, ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...
Agios maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion ...
A major hurdle in gene therapy is the efficient integration of a corrected gene into a patient's genome without mutating off-target sites. In a new paper, scientists explain having used CRISPR/Cas ...
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EdiGene, Inc. (“Company”, or “EdiGene”), today announced the first patient enrolled in multicenter Phase I clinical study of its investigational ...
VIJAYAWADA: Health Minister Satyakumar Yadav has said the government is committed to providing comprehensive support to thalassemia patients, who number 1,094 in Andhra Pradesh. Replying to a question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback